Albemarle (ALB) rallied sharply today, extending last week\u2019s post-earnings rebound as buyers leaned into improving fundamentals and a flurry of supportive analyst moves. Shares recently traded around $116<\/strong>, up roughly 5%\u20136% intraday<\/strong>, after touching an intraday high near $119<\/strong> on heavy volume. The move builds on gains since the company reported results on Nov. 5 that showed tighter cost control and smaller-than-feared losses amid still-soft lithium prices. <\/p>\n\n\n\n Fresh price-target lifts helped ignite today\u2019s bid. Mizuho<\/strong> raised its target to $110<\/strong> while reiterating Neutral, and UBS<\/strong> boosted its target to $107<\/strong>, signaling growing confidence that earnings and cash flow can stabilize as Albemarle pares spending and simplifies the portfolio. Momentum chatter also noted improving tape action across lithium names as investors rotate back into energy-transition winners. <\/p>\n\n\n\n Under the hood, the bullish narrative rests on three pillars. First, cost discipline<\/strong>: management has been trimming capex, rightsizing operations, and prioritizing returns, a theme that underpinned the better-than-expected Q3 print and sparked a relief rally. Reuters<\/strong> highlighted Albemarle\u2019s smaller loss and steadier volumes despite weak pricing, reinforcing the idea that downside earnings risk is narrowing. <\/p>\n\n\n\n Second, portfolio streamlining<\/strong>: in late October Albemarle agreed to divest a majority stake in its Ketjen refining-catalyst unit and its Eurecat JV interest for about $660 million<\/strong>, with proceeds earmarked for balance-sheet strengthening and core lithium\/bromine focus. That deal supports deleveraging and keeps capital pointed at the highest-return assets\u2014an investor priority in a volatile price environment. <\/p>\n\n\n\n Third, expectations management<\/strong>: after cutting 2025 guidance to reflect spot-price realities, Albemarle framed scenarios around an \u201cobserved market price\u201d of roughly $9\/kg LCE<\/strong> in 1H25 and laid out EBITDA ranges consistent with a careful reset. While hardly a blue-sky outlook, it provides a clearer base case for modeling and reduces the odds of fresh negative surprises.<\/p>\n\n\n\n Technically, today\u2019s surge pushed ALB through recent resistance created during the autumn consolidation, with buyers stepping in after the open near $113<\/strong> and carrying the stock toward the session highs. Traders pointed to improving breadth across the group and carry-through from Wednesday\u2019s lithium-supply headlines and target hikes; momentum blogs flagged ALB as a top intraday gainer. <\/p>\n\n\n\n Risks remain. Lithium pricing is still far below 2022 peaks, and any renewed down-draft could re-pressure margins and capex plans. Some on the Street continue to view the lithium bounce as tentative, and today\u2019s rally arrives after a strong multi-session run, raising the odds of near-term volatility. Even so, with cost actions taking hold, non-core assets being pruned, and coverage turning incrementally constructive, the market is signaling that Albemarle\u2019s earnings trough may be in<\/strong>\u2014and that the path back to free-cash-flow growth is becoming easier to visualize.<\/p>\n\n\n\n